204 related articles for article (PubMed ID: 9074395)
1. Apolipoprotein E in cerebrospinal fluid in 85-year-old subjects. Relation to dementia, apolipoprotein E polymorphism, cerebral atrophy, and white matter lesions.
Skoog I; Hesse C; Fredman P; Andreasson LA; Palmertz B; Blennow K
Arch Neurol; 1997 Mar; 54(3):267-72. PubMed ID: 9074395
[TBL] [Abstract][Full Text] [Related]
2. A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele.
Skoog I; Vanmechelen E; Andreasson LA; Palmertz B; Davidsson P; Hesse C; Blennow K
Neurodegeneration; 1995 Dec; 4(4):433-42. PubMed ID: 8846237
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias.
Barber R; Gholkar A; Scheltens P; Ballard C; McKeith IG; Morris CM; O'Brien JT
Arch Neurol; 1999 Aug; 56(8):961-5. PubMed ID: 10448801
[TBL] [Abstract][Full Text] [Related]
4. Deletion/insertion polymorphism of the angiotensin-converting enzyme gene and white matter hyperintensities in dementia: A pilot study.
Purandare N; Oude Voshaar RC; Davidson Y; Gibbons L; Hardicre J; Byrne J; McCollum C; Jackson A; Burns A; Mann DM
J Am Geriatr Soc; 2006 Sep; 54(9):1395-400. PubMed ID: 16970648
[TBL] [Abstract][Full Text] [Related]
5. A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia.
Skoog I; Wallin A; Fredman P; Hesse C; Aevarsson O; Karlsson I; Gottfries CG; Blennow K
Neurology; 1998 Apr; 50(4):966-71. PubMed ID: 9566380
[TBL] [Abstract][Full Text] [Related]
6. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging.
Jobst KA; Barnetson LP; Shepstone BJ
Int Psychogeriatr; 1998 Sep; 10(3):271-302. PubMed ID: 9785148
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.
Andreasen N; Hesse C; Davidsson P; Minthon L; Wallin A; Winblad B; Vanderstichele H; Vanmechelen E; Blennow K
Arch Neurol; 1999 Jun; 56(6):673-80. PubMed ID: 10369305
[TBL] [Abstract][Full Text] [Related]
9. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
Jobst KA; Barnetson LP; Shepstone BJ
Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E in cerebrospinal fluid from patients with Alzheimer's disease and other forms of dementia is reduced but without any correlation to the apoE4 isoform.
Landén M; Hesse C; Fredman P; Regland B; Wallin A; Blennow K
Dementia; 1996; 7(5):273-8. PubMed ID: 8872419
[TBL] [Abstract][Full Text] [Related]
11. High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.
Galasko D; Chang L; Motter R; Clark CM; Kaye J; Knopman D; Thomas R; Kholodenko D; Schenk D; Lieberburg I; Miller B; Green R; Basherad R; Kertiles L; Boss MA; Seubert P
Arch Neurol; 1998 Jul; 55(7):937-45. PubMed ID: 9678311
[TBL] [Abstract][Full Text] [Related]
12. Frequency of Alzheimer's disease and other dementias in a community outreach sample of Hispanics.
Fitten LJ; Ortiz F; Pontón M
J Am Geriatr Soc; 2001 Oct; 49(10):1301-8. PubMed ID: 11890488
[TBL] [Abstract][Full Text] [Related]
13. Low Cerebrospinal Fluid Aβ42 and Aβ40 are Related to White Matter Lesions in Cognitively Normal Elderly.
Skoog I; Kern S; Zetterberg H; Östling S; Börjesson-Hanson A; Guo X; Blennow K
J Alzheimers Dis; 2018; 62(4):1877-1886. PubMed ID: 29614655
[TBL] [Abstract][Full Text] [Related]
14. Coexisting cerebral infarction in Alzheimer's disease is associated with fast dementia progression: applying the National Institute for Neurological Disorders and Stroke/Association Internationale pour la Recherche et l'Enseignement en Neurosciences Neuroimaging Criteria in Alzheimer's Disease with Concomitant Cerebral Infarction.
Sheng B; Cheng LF; Law CB; Li HL; Yeung KM; Lau KK
J Am Geriatr Soc; 2007 Jun; 55(6):918-22. PubMed ID: 17537094
[TBL] [Abstract][Full Text] [Related]
15. Classification of vascular dementia in the Cardiovascular Health Study Cognition Study.
Lopez OL; Kuller LH; Becker JT; Jagust WJ; DeKosky ST; Fitzpatrick A; Breitner J; Lyketsos C; Kawas C; Carlson M
Neurology; 2005 May; 64(9):1539-47. PubMed ID: 15883314
[TBL] [Abstract][Full Text] [Related]
16. Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia. National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherche et l'Enseignement en Neurosciences.
Pohjasvaara T; Mäntylä R; Ylikoski R; Kaste M; Erkinjuntti T
Stroke; 2000 Dec; 31(12):2952-7. PubMed ID: 11108755
[TBL] [Abstract][Full Text] [Related]
17. Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer's disease.
Lefranc D; Vermersch P; Dallongeville J; Daems-Monpeurt C; Petit H; Delacourte A
Neurosci Lett; 1996 Jul; 212(2):91-4. PubMed ID: 8832646
[TBL] [Abstract][Full Text] [Related]
18. Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease.
Mehta PD; Pirttilä T; Mehta SP; Sersen EA; Aisen PS; Wisniewski HM
Arch Neurol; 2000 Jan; 57(1):100-5. PubMed ID: 10634455
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid apo E and apo A-I concentrations in early- and late-onset Alzheimer's disease.
Song H; Saito K; Seishima M; Noma A; Urakami K; Nakashima K
Neurosci Lett; 1997 Aug; 231(3):175-8. PubMed ID: 9300650
[TBL] [Abstract][Full Text] [Related]
20. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
Susanto TA; Pua EP; Zhou J;
J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
